Walgreens Pain Relief With Lidocaine Spray
NDC Package 0363-1026-03
Package Information
Walgreens Pain Relief With Lidocaine (lidocaine, phenylephrine hcl) sprays is helps relieve the local itching and discomfort associated with anorectal disorders or inflammation. This formulation utilizes a spray delivery system. Marketed by Walgreens Co, this product is identified by NDC 0363-1026 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 2590656 - lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Spray
- RxCUI: 2590656 - lidocaine 50 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Spray
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Local Anesthesia - [PE] (Physiologic Effect)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0363 - Walgreens Co
- 0363-1026 - Walgreens Pain Relief With Lidocaine
- 0363-1026-03 - 107.7 g in 1 CAN
- 0363-1026 - Walgreens Pain Relief With Lidocaine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0363-1026-03 identifies a specific commercial package of 107.7 g in 1 can of Walgreens Pain Relief With Lidocaine, a human over the counter drug labeled by Walgreens Co. This spray is formulated for topical use and contains lidocaine; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Walgreens Co on March 24, 2026. The current certification is valid through December 31, 2027.
How is this Walgreens Co product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00363102603. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.